Abstract:During our life, we are surrounded by continuous threats from a diverse range of invading pathogens. Our immune system has evolved multiple mechanisms to efficiently deal with these threats so as to prevent them from causing disease. Terminal differentiation of mature B cells into plasma cells (PC) - the antibody (Ab) secreting cells of the immune system - is critical for the generation of protective and long-lived humoral immune responses. Indeed, efficient production of antigen (Ag)-specific Ab by activated B cells underlies the success of most currently available vaccines. The mature B-cell pool is composed of several subsets, distinguished from one according to size, surface marker expression, location, and Ag exposure, and they all have the capacity to differentiate into PCs. For a B-cell to acquire the capacity to produce Abs, it must undergo an extensive differentiation process driven by changes in gene expression. Two broad categories of Ags exist that cause B-cell activation and differentiation: T cell dependent (TD) or T cell independent (TI). In addition to the B-cell subset and nature of the Ag, it is important to consider the cytokine environment that can also influence how B-cell differentiation is achieved. Thus, while many cytokines can induce Ab-secretion by B cells after activation with mimics of TD and TI stimuli in vitro, they can have different efficacies and specificities, and can often preferentially induce production of one particular Ig isotype over another. Here, we will provide an overview of in vitro studies (mouse and human origin) that evaluated the role of different cytokines in inducing the differentiation of distinct B-cell subsets to the PC lineage. We will place particular emphasis on IL-21, which has emerged as the most potent inducer of terminal B-cell differentiation in humans. We will also focus on the role of IL-21 and defects in B-cell function and how these contribute to human immunopathologies such as primary immunodeficiencies and B-cell mediated autoimmune conditions.

Here, There, and Anywhere? Arguments for and against the Physical Plasma Cell Survival Niche

New insights into the mechanisms regulating plasma cell survival and longevity

New insights into the ontogeny, diversity, maturation and survival of long-lived plasma cells

Assessing the Survival of Human Plasma Cells Ex Vivo

Predicting plasma cell retention and loss over a lifetime

In a wild germinal center, what determines survival of the fittest?

Fine-tuning spatial-temporal dynamics and surface receptor expression support plasma cell-intrinsic longevity

Plasma cell survival in the absence of B cell memory

Plasma cell biology: principles for therapeutic design

Unraveling the diversity and functions of tissue-resident plasma cells

Tuning of plasma cell lifespan by competition explains the longevity and heterogeneity of antibody persistence

Plasma cell differentiation during the germinal center reaction

Memory B cells and plasma cells: The differentiative continuum of humoral immunity

Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage

Specific pre-plasma cell states and local proliferation at the dark zone - medulla interface characterize germinal center-derived plasma cell differentiation in lymph node

Tissues of origin matter to plasma cell longevity

Phenotypic determinism and stochasticity in antibody repertoires of clonally expanded plasma cells

Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues

Temporal dynamics and genomic programming of plasma cell fates

Affinity alone does not drive long‐lived plasma cell differentiation

Long-term in vitro maintenance of plasma cells in a hydrogel-enclosed human bone marrow microphysiological 3D model system